GoodRx Holdings (GDRX) P/E Ratio
P/E Ratio as of Jul 1, 2025: 66.76
Average60.53
Median60.30
Minimum51.41
Maximum68.24
66.76
Past Month+14.00 (26.54%)
The P/E ratio for GoodRx Holdings (GDRX) is 66.76 as of Jul 1, 2025. This represents a decrease of -316.12% compared to its 12-month average P/E ratio of -30.89. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
GoodRx Holdings P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
GoodRx Holdings’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing GoodRx Holdings to industry peers.
GoodRx Holdings P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
GoodRx Holdings’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing GoodRx Holdings to industry peers.
GoodRx Holdings (GDRX) P/E Ratio Insights
See GoodRx Holdings’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in GoodRx Holdings (GDRX)
Order type
Buy in
Order amount
Est. shares
0 shares
GoodRx Holdings (GDRX) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jul 1, 2025 | $4.96 | 66.76 |
| Jun 2, 2025 | $3.82 | 51.41 |
| May 1, 2025 | $4.64 | 108.92 |
| Apr 1, 2025 | $4.43 | 103.99 |
| Mar 3, 2025 | $4.85 | 113.85 |
| Feb 3, 2025 | $4.70 | -120.20 |
| Jan 2, 2025 | $4.56 | -116.62 |
GoodRx Holdings (GDRX) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | 66.76 | -156.13% |
| 2024 | -118.93 | -163.90% |
| 2023 | 186.11 | -800.45% |
| 2022 | -26.57 | -94.53% |
| 2021 | -485.59 | +800.57% |
| 2020 | -53.92 | — |
FAQs About GoodRx Holdings (GDRX) P/E ratio
The latest P/E ratio of GoodRx Holdings (GDRX) is 66.76, as of Jul 1, 2025. This is calculated based on its current stock price and earnings per share (EPS).
GoodRx Holdings’s last 12-month average P/E ratio is -30.89, compared to its current P/E ratio of 66.76. This reflects a decrease of -316.12%.
GoodRx Holdings’s current P/E ratio of 66.76 is lower than its last 12-month average P/E of -30.89. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
GoodRx Holdings’s average P/E ratio over the last 3 years is -50.84. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
GoodRx Holdings’s average P/E ratio over the last 5 years is -32.15. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.